Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of ATRC-101 in Patients with Select Solid Tumors

NEXT STORY
Teleflex to Present at the 9th Annual SVB Leerink Global Healthcare Conference
PREV STORY
The global medical headwalls market is expected to reach US$ 1,318.68 Mn in 2027 from US$ 826.80 Mn in 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Poster on Celsion Corporation’s Phase I/II OVATION 2 Study Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women’s Cancer

author_avatar
NASDAQ Market News

Orchard Therapeutics Highlights 2020 Strategic Priorities

author_avatar
NASDAQ Market News

STRATA Skin Sciences Announces: Expanding Medical Coverage for Excimer Laser Treatment of Dermatological Conditions, Enlarging Company’s Addressable Market

author_avatar
NASDAQ Market News